BIOMAT Database Logo BIOMAT Database Logo

Treatment of acute lymphoblastic leukemia in adults with combination chemotherapy incorporating vindesine and prednisolone. 1983

Y Saito, and Y Uzuka

Seven adult patients with acute lymphoblastic leukemia (ALL) were treated with induction regimen incorporating vindesine (VDS) and prednisolone (VDS-P). After achieving complete remission, multidrug regimens for remission consolidation and maintenance were given. All patients achieved complete remission including five cases of continuous complete remission.

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014747 Vinblastine Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.) Vincaleukoblastine,Cellblastin,Lemblastine,Velban,Velbe,Vinblastin Hexal,Vinblastina Lilly,Vinblastine Sulfate,Vinblastinsulfat-Gry,Sulfate, Vinblastine
D014751 Vindesine Vinblastine derivative with antineoplastic activity against CANCER. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS). Compound 112531,Desacetylvinblastine Amide,Eldisine,Enison,NSC-245467,Vindesin,Vindesine Sulfate,NSC 245467,NSC245467,Sulfate, Vindesine

Related Publications

Y Saito, and Y Uzuka
[Combination chemotherapy of adult T-cell leukemia (ATL) using cyclophosphamide, vindesine and prednisolone (CV'P)].
December 1988, Nihon Gan Chiryo Gakkai shi,
Y Saito, and Y Uzuka
Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults.
January 1981, Cancer treatment reports,
Y Saito, and Y Uzuka
[Preliminary data on treatment with Vindesine in relapses of acute lymphoblastic leukemia].
October 1981, Haematologica,
Y Saito, and Y Uzuka
Vindesine induces rhabdomyolysis in patients with acute lymphoblastic leukemia.
January 2014, Chinese medical journal,
Y Saito, and Y Uzuka
Combination chemotherapy in relapsed childhood acute lymphoblastic leukemia.
February 1984, Cancer treatment reports,
Y Saito, and Y Uzuka
Treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy.
September 2006, Current hematologic malignancy reports,
Y Saito, and Y Uzuka
Combination chemotherapy for acute lymphoblastic leukaemia in adults.
January 1978, British medical journal,
Y Saito, and Y Uzuka
Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy.
January 1989, Blood,
Y Saito, and Y Uzuka
Prognostic factors and treatment response in acute lymphoblastic leukemia of children and adults treated with a non aggressive combination chemotherapy.
February 1980, Haematologica,
Y Saito, and Y Uzuka
Combination chemotherapy with daunorubicin, cytosine arabinoside and prednisolone (DAP) in acute nonlymphocytic leukemia.
July 1981, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
Copied contents to your clipboard!